Biomedicine and Chemical Sciences
2023, Volume 2, Issue 2 : 163-165 doi: https://doi.org/10.48112/bcs.v2i2.349
Research Article
Biomarkers are Significant Clinical Features in Obsessive-Compulsive Disorder
Received
Nov. 28, 2022
Revised
Jan. 18, 2023
Accepted
Jan. 20, 2023
Published
April 1, 2023
Abstract

Letter to American Psychiatric Association

Keywords
REFERENCES
  1. Abramovitch, A., McCormack, B., Brunner, D., Johnson, M., & Wofford, N. (2019). The impact of symptom severity on cognitive function in obsessive-compulsive disorder: A meta-analysis. Clinical psychology review, 67, 36-44. https://doi.org/10.1016/j.cpr.2018.09.003
  2. American Psychiatric Association, D., & American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (Vol. 5, No. 5). Washington, DC: American psychiatric association.
  3. Balandeh, E., Karimian, M., Behjati, M., & Mohammadi, A. H. (2021). Serum vitamins and homocysteine levels in obsessive-compulsive disorder: a systematic review and meta-analysis. Neuropsychobiology, 80(6), 502-515. https://doi.org/10.1159/000514075
  4. Bey, K., Campos-Martin, R., Klawohn, J., Reuter, B., Grützmann, R., Riesel, A., ... & Kathmann, N. (2022). Hypermethylation of the oxytocin receptor gene (OXTR) in obsessive-compulsive disorder: Further evidence for a biomarker of disease and treatment response. Epigenetics, 17(6), 642-652. https://doi.org/10.1080/15592294.2021.1943864
  5. Bijl, R. V., Ravelli, A., & van ZESSEN, G. (1998). Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Social psychiatry and psychiatric epidemiology, 33, 587-595. https://doi.org/10.1007/s001270050098
  6. Bobes, J., González, M. P., Bascaran, M. T., Arango, C., Saiz, P. A., & Bousono, M. (2001). Quality of life and disability in patients with obsessive-compulsive disorder. European psychiatry, 16(4), 239-245. https://doi.org/10.1016/S0924-9338(01)00571-5
  7. Cosco, T. D., Pillinger, T., Emam, H., Solmi, M., Budhdeo, S., Matthew Prina, A., ... & Carvalho, A. F. (2019). Immune aberrations in obsessive-compulsive disorder: a systematic review and meta-analysis. Molecular neurobiology, 56, 4751-4759. https://doi.org/10.1007/s12035-018-1409-x
  8. Endres, D., Pollak, T. A., Bechter, K., Denzel, D., Pitsch, K., Nickel, K., ... & Schiele, M. A. (2022). Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype?. Translational psychiatry, 12(1), 5. https://doi.org/10.1038/s41398-021-01700-4
  9. Gray, S. M., & Bloch, M. H. (2012). Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Current psychiatry reports, 14, 220-228. https://doi.org/10.1007/s11920-012-0272-0
  10. Hao, L. S., Du, Y., Chen, L., Jiao, Y. G., & Cheng, Y. (2022). Brain-derived neurotrophic factor as a biomarker for obsessive-compulsive disorder: A meta-analysis. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2022.05.026
  11. Hollander, E. (1998). Treatment of obsessive-compulsive spectrum disorders with SSRIs. The British Journal of Psychiatry, 173(S35), 7-12. https://doi.org/10.1192/S0007125000297845
  12. Maia, A., Oliveira, J., Lajnef, M., Mallet, L., Tamouza, R., Leboyer, M., & Oliveira‐Maia, A. J. (2019). Oxidative and nitrosative stress markers in obsessive–compulsive disorder: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica, 139(5), 420-433. https://doi.org/10.1111/acps.13026
  13. Mohammadi, A. H., Balandeh, E., & Milajerdi, A. (2021). Malondialdehyde concentrations in obsessive–compulsive disorder: a systematic review and meta-analysis. Annals of general psychiatry, 20(1), 34. https://doi.org/10.1186/s12991-021-00354-2
  14. Mohammadi, A. H., Balandeh, E., Hasani, J., Karimian, M., Pourfarzam, M., Bahmani, F., & Namazi, G. (2021). The Oxidative Status and Na+/K+-ATPase Activity in Obsessive-Compulsive Disorder: A Case Control Study.
  15. Piras, F., Piras, F., Caltagirone, C., & Spalletta, G. (2013). Brain circuitries of obsessive compulsive disorder: a systematic review and meta-analysis of diffusion tensor imaging studies. Neuroscience & Biobehavioral Reviews, 37(10), 2856-2877. https://doi.org/10.1016/j.neubiorev.2013.10.008
  16. Renna, M. E., O'Toole, M. S., Spaeth, P. E., Lekander, M., & Mennin, D. S. (2018). The association between anxiety, traumatic stress, and obsessive–compulsive disorders and chronic inflammation: A systematic review and meta‐analysis. Depression and anxiety, 35(11), 1081-1094. https://doi.org/10.1002/da.22790
  17. Rotge, J. Y., Guehl, D., Dilharreguy, B., Tignol, J., Bioulac, B., Allard, M., ... & Aouizerate, B. (2009). Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biological psychiatry, 65(1), 75-83. https://doi.org/10.1016/j.biopsych.2008.06.019
  18. Ruscio, A. M., Stein, D. J., Chiu, W. T., & Kessler, R. C. (2010). The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Molecular psychiatry, 15(1), 53-63. https://doi.org/10.1038/mp.2008.94
  19. Sina, M., Ahmadiani, A., Asadi, S., & Shams, J. (2018). Association of serotonin receptor 2a haplotypes with obsessive–compulsive disorder and its treatment response in iranian patients: a genetic and pharmacogenetic study. Neuropsychiatric Disease and Treatment, 1199-1209.
  20. Sousa-Lima, J., Moreira, P. S., Raposo-Lima, C., Sousa, N., & Morgado, P. (2019). Relationship between obsessive compulsive disorder and cortisol: Systematic review and meta-analysis. European Neuropsychopharmacology, 29(11), 1185-1198. https://doi.org/10.1016/j.euroneuro.2019.09.001
  21. Stein, D. J., Costa, D. L., Lochner, C., Miguel, E. C., Reddy, Y. J., Shavitt, R. G., ... & Simpson, H. B. (2019). Obsessive–compulsive disorder. Nature reviews Disease primers, 5(1), 52. https://doi.org/10.1038/s41572-019-0102-3
  22. Stein, D. J., Roberts, M., Hollander, E., Rowland, C., & Serebro, P. (1996). Quality of life and pharmaco-economic aspects of obsessive-compulsive disorder. A South African survey. South African medical journal= Suid-Afrikaanse tydskrif vir geneeskunde, 86(12 Suppl), 1579-1582.
  23. Taylor, S. (2016). Disorder‐specific genetic factors in obsessive‐compulsive disorder: A comprehensive meta‐analysis. American journal of medical genetics part B: neuropsychiatric genetics, 171(3), 325-332. https://doi.org/10.1002/ajmg.b.32407
  24. Yan, S., Liu, H., Yu, Y., Han, N., & Du, W. (2022). Changes of Serum Homocysteine and Vitamin B12, but Not Folate Are Correlated With Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis of Case-Control Studies. Frontiers in Psychiatry, 13.
  25. Zai, G., Zai, C. C., Arnold, P. D., Freeman, N., Burroughs, E., Kennedy, J. L., & Richter, M. A. (2015). Meta-analysis and association of brain-derived neurotrophic factor (BDNF) gene with obsessive-compulsive disorder. Psychiatric genetics, 25(2), 95-96. https://doi.org/10.1097/ypg.0000000000000077
Recommended Articles
Research Article Open Access
Investigation of Tritrichomonas Foetus in Cattle Using Different Methods in Basrah City – Iraq
2023, Volume 2, Issue 1 : 39-43
DOI: https://doi.org/10.48112/bcs.v2i1.334
Original Article Open Access
A FRAMEWORK OF MONOCLONAL ANTIBODIES AND RELATED PRODUCTION ENGINEERING
2025, Volume 4, Issue 4 : 26-34
Research Article Open Access
The Role of Vitamin D and Zinc In Facing COVID-19 Injury
2022, Volume 1, Issue 1 : 6-10
DOI: https://doi.org/10.48112/bcs.v1i1.76
Research Article Open Access
Prevalence and Risk Factors of Obesity in Children
2022, Volume 1, Issue 1 : 20-23
DOI: https://doi.org/10.48112/bcs.v1i1.81
Biomedicine and Chemical Sciences journal thumbnail
Volume 2, Issue 2
Citations
2 Views
0 Downloads
Share this article
License
Copyright (c) Biomedicine and Chemical Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Biomed. Chem. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Biomedicine and Chemical Sciences Logo
Biomedicine and Chemical Sciences
About Us
Biomedicine and Chemical Sciences (BCS), an international journal, publishes double blind peer-reviewed full-length, original papers, reviews or letters. BCS covers the latest developments in various fields of biomedicine such as cardiology, immunology, genetics, environmental health, neurology, oncology and toxicology
Support
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright Biomedicine and Chemical Sciences (BCS). All Rights Reserved.